Skip to content
Clinical Trials – home

Fakultni Nemocnice Plzen

Verifiedinfo

Czechia Alej Svobody 923/80, 323 00 Plzen, Czechia

  • 31 trials recruiting
  • Plasma cell myeloma · Chronic lymphocytic leukaemia · B-cell small lymphocytic lymphoma
  • Adults and children

About Specializations

Fakultni Nemocnice Plzen in Plzen, Czechia specialises in clinical trials of conditions such as Plasma cell myeloma, Chronic lymphocytic leukaemia, B-cell small lymphocytic lymphoma, Acute myeloid leukaemia, and other specialisations. This site conducts important research.

Main research areas of the site

Hematologic Malignancies

The medical center is at the forefront of research in hematologic malignancies, focusing on innovative treatments for conditions such as Primary Myelofibrosis, Chronic Myeloid Leukemia, and Multiple Myeloma. The center's work in this area aims to improve patient outcomes through advanced therapeutic strategies.

  • Primary Myelofibrosis
  • Chronic Myeloid Leukemia
  • Multiple Myeloma

By integrating cutting-edge research with clinical practice, the center is enhancing the understanding and treatment of these complex diseases.

Oncology

Specializing in oncology, the center conducts pivotal studies on various cancers, including Renal Cell Carcinoma and Non-small Cell Lung Cancer. These studies are crucial for developing new treatment protocols and improving survival rates.

  • Renal Cell Carcinoma
  • Non-small Cell Lung Cancer
  • Diffuse Large B-cell Lymphoma

The center's commitment to oncology research is evident in its comprehensive approach to understanding cancer biology and treatment.

Cardiovascular Diseases

In the realm of cardiovascular diseases, the center is pioneering research on Chronic Heart Failure and Atherosclerotic Cardiovascular Disease. These efforts are directed towards developing novel therapies that address the underlying mechanisms of these conditions.

  • Chronic Heart Failure
  • Atherosclerotic Cardiovascular Disease

Through its research, the center is contributing to the advancement of cardiovascular medicine, offering hope for improved patient care.

Dermatology

The center's dermatology research focuses on Moderate to Severe Plaque Psoriasis and Hidradenitis Suppurativa. By exploring new treatment modalities, the center aims to enhance the quality of life for patients with these chronic skin conditions.

  • Moderate to Severe Plaque Psoriasis
  • Hidradenitis Suppurativa

Innovative research in dermatology is paving the way for more effective and personalized treatment options.

Gastroenterology

In gastroenterology, the center is advancing the understanding of Short Bowel Syndrome and Cirrhosis. Research efforts are focused on improving long-term outcomes and quality of life for patients with these challenging conditions.

  • Short Bowel Syndrome
  • Cirrhosis

The center's work in this field is instrumental in developing new therapeutic approaches and enhancing patient care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Alej Svobody 923/80323 00 PlzenCzechia
Recruiting now
31 trials
Conditions studied
70
Partner status
Verified

More sites in PlzenCzechia

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

96 clinical trials

Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:LUNSEKIMIG
  • Sponsor:Sanofi-Aventis Recherche & Developpement
Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Ezetimibe
  • Sponsor:NewAmsterdam Pharma B.V.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Oxymetazoline Hydrochloride
  • Sponsor:Santen
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Finerenone
  • Sponsor:Colorado Prevention Center
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Aflibercept
  • Sponsor:Amgen Inc.
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Teclistamab
  • Sponsor:Janssen Cilag International
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Bosutinib
  • Sponsor:Novartis Pharma AG
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:BeOne Medicines I GmbH
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.